Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,057,050,945
-
Share change
-
+6,306,975
-
Total reported value
-
$143,087,307,788
-
Put/Call ratio
-
66%
-
Price per share
-
$135.40
-
Number of holders
-
2,927
-
Value change
-
+$940,141,924
-
Number of buys
-
1,432
-
Number of sells
-
991
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q4 2021
As of 31 Dec 2021,
AbbVie Inc. - Common Stock (ABBV) was held by
2,927 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,057,050,945 shares.
The largest 10 holders included
VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, BANK OF AMERICA CORP /DE/, FRANKLIN RESOURCES INC, and MORGAN STANLEY.
This page lists
2,953
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.